peripheral nervous system L10-13 Flashcards
autonomic
controls smooth muscle and glands
involuntary
either sympathetic/ parasympathetic
somatic
motor innervation of skeletal muscles
voluntary
synthetic enzyme needed for ACh
CAT
chlineacetyl transferase
ACh receptor types
nicotinic
muscarinic
metabolic enzyme for ACh
acetylcholinesterase breaks down into choline + acetate
muscarinic ACh receptor
post-ganglionic parasympathetic synapses
G-protein coupled
7 transmembrane spanning
slow
nicotinic ACh
sym/para excitatory
NMJ
ligand-gated
4/5 sub-unit structure
ion channel coupled
fast
muscarinic agonist example
carbachol/ pilocarpine
(glaucoma treatment via ciliary muscle contraction)
(xerostomia treatment w saliva secretion stimulation)
muscarinic antagonist example
atropine-like drugs (pupil dilation/ decrease in oral/ resp secretions)
atropine> bradychardia resus
hyoscine > motion sickness
ipatropium > asthma
neuronal nicotinic agonists
activate symp and para systems
excitatory of brain and autonomic ganglia
not clinically useful as autonomic confusion occurs
neuronal nicotinic agonist example
suxemethonium
paralysis/ muscle relaxation
neuronal nicotinic antagonist example
tubocurarine
hyperpolarization/ EPP inhibition
muscle fibre relaxation and paralysis
noradrenaline receptors
alpha/ beta
NA production process
tyrosine > DOPA > DA> NA
(tyr hydroxylase) (DOPA decarboxylase) (DA B-hydroxylase)
NA reuptake
monoamine oxidase breakdown into amines
NA synthesis/ storage/ release/ receptor interaction/termination
tyrosine/ tyrosine hydroxylase etc
vesicle storage
exocytotic release
a/b receptor interaction
terminated via uptake/ recycle via monoamine oxidase
noradrenergic receptors
a1/ a2
b1/ b2/ b3
metabotropic
slow
a2
presynsaptic
inhibits neurotransmitter release
a1
mediate sympathetic effects
b1 effects
^HR
B2 effects
bronchodilation
B3 effects
^lipolysis
NA agonists
adrenaline
dobutamine
salbutamol
clenbuterol
adrenaline agonist NA effect
all NA (vasoconstriction/ smooth muscle contraction/ cardiac stimulation/ bronchial smooth muscle relaxation)
gut breakdown
clonidine
a2 agonist
hypertension treatment
reduces NA release
dobutamine
selective B1 agonist
^ cardiac rate/ force
treats heart failure
salbutamol
B2 agonist
bronchodilation
asthma treatment
clenbuterol
B2/ B3 agonist
bronchodilation > asthma
lipolysis > weight loss
NA antagonists
prazosin
tamsulson
propranolol
atenolol
timolol
prazosin
selective a1 antagonist
hypertension treatment via orthostatic / postural hypotension
tamsulson
selective a1 antagonist
treatment for prostate hyperplasia
propranolol
B1/B2 antagonist
treats angina/ hypotension
:(bronchoconstriction
atenolol
B1 antagonist
angina/ hypotension treatment
:(receptor supersensitivity
timolol
B2 antagonist
treats glaucoma via ciliary contraction
methyldopa
false substrate for DOPA decarboxylase, decreasing NA conc
hypertension treatment
reserpine
disrupts storage of NA in vesicles
hypertension treatment
desipramine
tricyclic antidepressants
reboxetine
selective NA reuptake inhibitors
trangicypramine
blocks MAO
respiration regulation processes
autonomic regulation (resp centre in bronchial smooth muscle)
voluntary control (cortex)
spontaneous rythmic discharge (resp centre in medulla oblongata)
parasympathetic innervation of autonomic regulation
bronchoconstriction and ^mucus secretions
glands/ vascular and smooth muscle
sympathetic innervation
bronchodilation and smooth muscle relaxation
bronchial smooth muscle
3 neuronal pathways
sympathetic innervation
parasympathetic innervation
NANC (noradrenergic noncholinergic) innervation
factors affecting respiration
endogenous stimuli
exogenous chemicals
physical stimuli
asthma
smooth muscle contraction and therefore airway obstruction
mucus hypersecretion
airway inflammation
asthma phases
immediate (bronchocontriction)
delayed (inflammation/ airway damage)
bronchospasm
initial mast cell interaction, mucus secretion, chemotoxin release
inflammation
cytokine influx, oedema, mucus secretion
tissue damage
bronchospasm treatment
bronchodilator
B2 agonist
muscarinic antagonist
B2 adrenergic agonist asthma short/ long term treatment
short > salbutamol
long > salmeterol
xanthines
caffeine theobromine derivatives
bronchodilation
anti inflam
xanthine example
theophylline
narrow TI / well-absorbed
glucocorticoid function
anti inflam
sodium cromolyn
mast cell stabilizer
prevents histimine and inflam release
anti-asthma drug side effects
B2 recep agonist> tremor/ tolerance
glucocorticoids> cushing
xanthines > tremor/ tachycardia
v-gated ion channel components
a, B1, B2
alpha sub-unit of v-gated channel
single polypeptide of 4 domains w 6 a-helical regions
hydrophobic domains w sensors changing orientation w voltage
B sub-unit of v-gated channel
B2 covalently linked to a
both banchor to lipid membrane
local anaesthetic interaction on v-gated ion channel
binds in ionised form to a sub-unit to physically plug
anaesthetic general structure
aromatic group (lipid solubility)
ester/ amide (hydrolysis determining duration/ esters metabolised in plasma by esterases and amides metabolised by CYP in liver)
amine group (ionization at physio pH)
anaesthetic process
- injected as HCl in acid solution
- dissociates and pH^
- free base enters axon
- re-ionized portion enters Na+ channels
anaesthetic manipulation
coadmin of adrenaline prolongs duration
alkaline solution accelerates onset speed
nosciceptive fibres vs motor axons
small diameter and v sensitive vs large diameter and less sensitive
use-dependent block
depth of block increases w increasing a.p frequency
3 ion channel states
resting
open
inactive